Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han1, Zhida Liu1, Yunjia Zhang2
1Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Abstract:
High-dose radiation activates caspases in tumor cells to produce abundant DNA fragments for DNA sensing in antigen-presenting cells, but the intrinsic DNA sensing in tumor cells after radiation is rather limited. Here we demonstrate that irradiated tumor cells hijack caspase 9 signaling to suppress intrinsic DNA sensing. Instead of apoptotic genomic DNA, tumor-derived mitochondrial DNA triggers intrinsic DNA sensing. Specifically, loss of mitochondrial DNA sensing in Casp9-/- tumors abolishes the enhanced therapeutic effect of radiation. We demonstrated that combining emricasan, a pan-caspase inhibitor, with radiation generates synergistic therapeutic effects. Moreover, loss of CASP9 signaling in tumor cells led to adaptive resistance by upregulating programmed death-ligand 1 (PD-L1) and resulted in tumor relapse. Additional anti-PD-L1 blockade can further overcome this acquired immune resistance. Therefore, combining radiation with a caspase inhibitor and anti-PD-L1 can effectively control tumors by sequentially blocking both intrinsic and extrinsic inhibitory signaling.
Insights
High-dose radiation triggers tumor cells to suppress intrinsic DNA sensing via caspase 9 signaling, using mitochondrial DNA instead of apoptotic DNA. Combining radiation with caspase inhibitors and anti-PD-L1 therapy overcomes tumor resistance.
Area of Science:
- Cancer biology
- Immunology
- Radiation oncology
Background:
- High-dose radiation therapy generates DNA fragments that activate antigen-presenting cells but has limited intrinsic DNA sensing in tumor cells.
- Tumor cells can suppress their own intrinsic DNA sensing mechanisms following radiation exposure.
Purpose of the Study:
- To investigate how irradiated tumor cells suppress intrinsic DNA sensing.
- To explore the role of caspase 9 signaling in this process.
- To evaluate therapeutic strategies combining radiation with caspase inhibitors and immune checkpoint blockade.
Main Methods:
- Analysis of caspase 9 signaling in irradiated tumor cells.
- Investigation of DNA sensing pathways, distinguishing between apoptotic and mitochondrial DNA.
- Assessment of therapeutic effects of radiation, emricasan (pan-caspase inhibitor), and anti-PD-L1 blockade in preclinical models.
- Evaluation of programmed death-ligand 1 (PD-L1) expression and its role in adaptive resistance.
Main Results:
- Irradiated tumor cells hijack caspase 9 signaling to suppress intrinsic DNA sensing, utilizing tumor-derived mitochondrial DNA.
- Loss of caspase 9 or mitochondrial DNA sensing in tumors abrogates the enhanced therapeutic effect of radiation.
- Combining radiation with emricasan demonstrates synergistic therapeutic effects.
- Loss of caspase 9 signaling induces adaptive resistance via PD-L1 upregulation, leading to tumor relapse.
- Combined blockade of caspase 9 and PD-L1 signaling effectively controls tumors.
Conclusions:
- Caspase 9 signaling is a critical regulator of intrinsic DNA sensing in irradiated tumor cells, with mitochondrial DNA playing a key role.
- Targeting caspase 9 with inhibitors and combining with radiation and anti-PD-L1 therapy offers a promising strategy to overcome tumor resistance and enhance treatment efficacy.
Related Concept Videos
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Extrinsic Apoptotic Pathway
Treatment Resistant Cancers
The Intrinsic Apoptotic Pathway


